Companies › Cullinan Therapeutics
3 active drug programs in 7 registered trials: 7 Phase 1; Oncology, Immunology; next expected readout Dec 2026.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| CLN-978 CD19-directed T cell engager | CD19 | Phase 1 | NHL; SLE; Rheumatoid Arthritis (RA; Sjögren | Dec 2026 |
| CLN-619 Anti-MICA/MICB monoclonal antibody | MICA, MICB | Phase 1 | Advanced Solid Tumor; Multiple Myeloma | Mar 2027 |
| CLN-049 FLT3 x CD3 bispecific T cell engager | FLT3, CD3E | Phase 1 | Relapsed/Refractory Acute Myeloid Leukemia (AML) | Dec 2029 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT05879744 | CLN-978 | Phase 1 | NHL | Oncology | Jun 2024 |
| NCT05117476 | CLN-619 | Phase 1 | Advanced Solid Tumor | Oncology | Mar 2026 |
| NCT06613360 | CLN-978 | Phase 1 | SLE | Immunology | Dec 2026 |
| NCT06381141 | CLN-619 | Phase 1 | Multiple Myeloma | Oncology | Mar 2027 |
| NCT06994143 | CLN-978 | Phase 1 | Rheumatoid Arthritis (RA | Immunology | Dec 2027 |
| NCT07041099 | CLN-978 | Phase 1 | Sjögren | Immunology | Mar 2028 |
| NCT05143996 | CLN-049 | Phase 1 | Relapsed/Refractory Acute Myeloid Leukemia (AML) | Oncology | Dec 2029 |
Cash and short-term investments of $290m on 2026-09-30; operating cash outflow about $171m a year; runway about 20 months at that burn, to Jun 2028
Press releases filed as 8-K in the last year:
Held by 9 of the 39 life-science funds Phaseline follows through their 13F filings. Who holds what.
Bristol-Myers Squibb Roche Johnson & Johnson (Janssen) Gilead Sciences Chongqing Precision Biotech Amgen AstraZeneca Allogene Therapeutics Miltenyi Biomedicine Novartis
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.